What evidence is available?

Available source material is summarized from the collected research outputs and should be reviewed editorially before publication. [2]

Are there safety considerations?

Ibogaine-related topics require careful clinical and safety review before any interpretation is published. [3]

Should this draft be reviewed?

Yes. This fallback draft was generated to prevent the pipeline from getting stuck and should be reviewed before publishing.

Ibogaine Treatment for NBA Players

Overview

Ibogaine has begun to intersect with professional basketball mainly through individual former NBA players seeking addiction or mental‑health treatment at offshore clinics and through one ex‑NBA player Stéphane Lasme helping build an iboga/ibogaine industry in Gabon. 1 2 6 7 There are no controlled clinical trials specifically in NBA athletes, so what exists are case‑style accounts, media reports, and extrapolations from broader ibogaine research in elite athletes, veterans, and general addiction populations.

Below is a detailed dossier focused on: - Known NBA or ex‑NBA figures connected to iboga/ibogaine - What is actually documented versus speculative - Relevant ibogaine science that plausibly translates to NBA‑type use cases opioid/alcohol/stimulant use disorders, trauma, depression, TBI - Safety/cardiac risk, legal status, programs, costs, and expert positions - 2023–2026 developments that may pull elite athletes including NBA into ibogaine treatment --- 1. Known NBA‑Linked Iboga/Ibogaine Stories 1.1 Lamar Odom – “The Long Game” and Ambio Life Sciences Former NBA champion Lamar Odom has publicly discussed psychedelic‑assisted addiction and mental‑health treatments, and in 2023–2024 he became a focal point in media coverage involving Ambio Life Sciences and “The Long Game” interview.^[1]

7 - Source: A March 2023 PRNewswire release titled “Lamar Odom: The Long Game explores NBA star's ibogaine and addiction recovery journey at Ambio Life Sciences in exclusive YouTube interview” describes Odom’s experience. 7 Key elements from that release: - It refers to Odom’s “ibogaine and addiction recovery journey” at Ambio Life Sciences.

7 - Ambio is described as a research‑oriented life sciences company exploring ibogaine and related molecules for addiction treatment. 7 - The piece positions Odom’s story as part of a broader “psychedelic renaissance” in addiction care, with a focus on ibogaine as a non‑opioid medication for substance use disorders.

7 Important caveat: - Publicly available details are sparse on medical specifics: - No disclosed dose, route, or mg/kg regimen. - No report of ECG parameters, QTc, or detailed adverse‑event monitoring.^[2]

Research findings

ten iboga exports because much iboga is illegally smuggled. 2 Lasme’s role: - Co‑founder of a private investment firm Stedde Capital investing in: - Export of iboga.^[1]

2 6 1.2.3 Beond Ibogaine Profile The clinic Beond Ibogaine Mexico features a profile: “Stephane Lasme: Respecting and Investing in Iboga.” 6 Key points: 6 - Describes Lasme as a retired professional basketball player and co‑founder of Stedde Capital. 6 - Notes his background and commitment to sustainable iboga sourcing and Gabon‑centered benefit‑sharing.

6 Again, there is no published record of Lasme himself undergoing ibogaine treatment as a patient, nor of other NBA players receiving treatment at his future Gabon facility. His importance is structural and economic, integrating an ex‑NBA athlete into ibogaine’s emerging global supply chain.

1.3 Other NBA Players – Public Record Status As of mid‑2026, systematic searching across mainstream media, medical literature, and specialized ibogaine advocacy orgs does not yield additional named NBA players with documented iboga/ibogaine treatment, beyond: - Lamar Odom – explicit association with ibogaine via Ambio Life Sciences press coverage. 7 - Stéphane Lasme – ex‑NBA player and iboga entrepreneur, not publicly an ibogaine patient.^[2]

1 2 6 There are, however, adjacent trends: - Psychedelic‑assisted therapy psilocybin, ketamine, MDMA openly discussed by current and former NFL, NHL, MMA, and Olympic athletes; ibogaine is often mentioned in the same ecosystem, particularly for opioid painkiller dependence and TBI‑related mood symptoms. - Americans for Ibogaine, an advocacy group, lists athletes among their ambassadors, though publicly named ambassadors on the site are largely veterans, first responders, and clinicians; no NBA‑specific names are evident in available snapshots.^[3]

Safety considerations

ans treated in Mexico often at centers like Clear Sky Recovery or other clinics. - According to Microdose, the study found that ibogaine + 5‑MeO‑DMT led to reductions in PTSD symptoms.

1 Typical features from the veteran study literature: - n: ~30 U.S. - Intervention: - 1–2 sessions of ibogaine oral, 10–20 mg/kg.

- Followed by 5‑MeO‑DMT vaporized or intranasal, single high‑dose. - Outcome measures: - PTSD scales e.g., PCL‑5.^[2]

- Depression/anxiety scores e.g., PHQ‑9, GAD‑7. - Results summarized in Microdose and similar to reported veteran studies: - Meaningful decreases in PTSD, depression, and anxiety at follow‑up.^[3]

1 - Many participants report profound psychological insights and behavioral change. Relevance for NBA players: - Elite athletes and SOF veterans share: - High exposure to trauma physical and psychological.

Legal and clinical context

ustralia: - Ibogaine is generally controlled or effectively prohibited for clinical use, with exceptions for small research trials. - New Zealand, Brazil, South Africa: - Patchwork of regulation; some people travel there for treatment, but the main magnet for North American athletes remains Mexico and Costa Rica.

4.2 Types of Clinics Serving or Potentially Serving NBA Players While clinics rarely disclose sports‑league affiliation, the same centers that serve NFL/NHL and celebrity clients are likely to be used by NBA alumni. Common features: - Located in Mexico Tijuana, Playa del Carmen, Cancun and Costa Rica.^[2]

- “Peak performance” / “reset” for entrepreneurs and athletes. Typical protocols: - Pre‑treatment: - Medical intake, ECG, labs.^[3]

- Dosing: - Flood dose: ~10–20 mg/kg ibogaine HCl oral. - Sometimes preceded or followed by test doses or “booster” doses.

- Monitoring: - Continuous cardiac monitoring for 24–72 hours. - An on‑site physician or anesthesiologist.

Evidence limitations

Ibogaine A4I is an advocacy organization pushing for ibogaine research and access in the US. 5 - Its ambassadors include veterans, clinicians, advocates, and some athletes—though no publicly documented NBA ambassadors as of accessible snapshots.^[2]

5 - Their messaging: - Ibogaine is a “breakthrough” addiction treatment that merits clinical development. - It can drastically reduce opioid withdrawal and craving —a major issue for injured populations, including professional athletes.^[3]

This kind of advocacy creates an environment where NBA players might: - Hear about ibogaine from veteran